Evidence map›Paper›PMID 34708087›Full record

ArticleFrontiers in cardiovascular medicine2021

Loss of Function in Dopamine D3 Receptor Attenuates Left Ventricular Cardiac Fibroblast Migration and Proliferation

Andrew Kisling, Shannon Byrne, Rohan U Parekh, Deepthy Melit-Thomas, Lisandra E de Castro Brás, Robert M Lust, Stefan Clemens, Srinivas Sriramula, Laxmansa C Katwa

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Dopamine receptors and organ fibrosis.Biochemistry and biophysics reports · 2025
    Review
  5. Dopamine Receptor D1 Is Exempt from Transforming Growth FactorThe Journal of pharmacology and experimental therapeutics · 2023
    Article
  6. Dopamine, Immunity, and Disease.Pharmacological reviews · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Andrew KislingDepartment of Physiology, Brody School of Medicine at East Carolina University, Greenville, NC, United States.
Shannon ByrneDepartment of Physiology, Brody School of Medicine at East Carolina University, Greenville, NC, United States.
Rohan U ParekhDepartment of Pharmacology and Toxicology, Brody School of Medicine at East Carolina University, Greenville, NC, United States.
Deepthy Melit-ThomasDepartment of Physiology, Brody School of Medicine at East Carolina University, Greenville, NC, United States.
Lisandra E de Castro BrásDepartment of Physiology, Brody School of Medicine at East Carolina University, Greenville, NC, United States.
Robert M LustDepartment of Physiology, Brody School of Medicine at East Carolina University, Greenville, NC, United States.
Stefan ClemensDepartment of Physiology, Brody School of Medicine at East Carolina University, Greenville, NC, United States.
Srinivas SriramulaDepartment of Pharmacology and Toxicology, Brody School of Medicine at East Carolina University, Greenville, NC, United States.
Laxmansa C KatwaDepartment of Physiology, Brody School of Medicine at East Carolina University, Greenville, NC, United States.
East Carolina University · US

Funding

Neuroimmune Mechanisms of Kinin B1 Receptor in HypertensionR01HL153115 · NHLBI · EAST CAROLINA UNIVERSITY · PI SRIRAMULA, SRINIVAS · 2020 to 2024
$1.8M
NHLBI NIH HHS R01 HL153115
6 · The paper itself

Abstract

Evidence suggests the existence of an intracardiac dopaminergic system that plays a pivotal role in regulating cardiac function and fibrosis through G-protein coupled receptors, particularly mediated by dopamine receptor 3 (D3R). However, the expression of dopamine receptors in cardiac tissue and their role in cardiac fibroblast function is unclear. In this brief report, first we determined expression of D1R and D3R both in left ventricle (LV) tissue and fibroblasts. Then, we explored the role of D3R in the proliferation and migration of fibroblast cell cultures using both genetic and pharmaceutical approaches; specifically, we compared cardiac fibroblasts isolated from LV of wild type (WT) and D3R knockout (D3KO) mice in response to D3R-specific pharmacological agents. Finally, we determined if loss of D3R function could significantly alter LV fibroblast expression of collagen types I (Col1a1) and III (Col3a1). Cardiac fibroblast proliferation was attenuated in D3KO cells, mimicking the behavior of WT cardiac fibroblasts treated with D3R antagonist. In response to scratch injury, WT cardiac fibroblasts treated with the D3R agonist, pramipexole, displayed enhanced migration compared to control WT and D3KO cells. Loss of function in D3R resulted in attenuation of both proliferation and migration in response to scratch injury, and significantly increased the expression of Col3a1 in LV fibroblasts. These findings suggest that D3R may mediate cardiac fibroblast function during the wound healing response. To our knowledge this is the first report of D3R's expression and functional significance directly in mouse cardiac fibroblasts.

Indexed as

cardiac fibroblastsD3R agonistD3R antagonistdopamine D1 receptordopamine D3 receptormigrationproliferationscratch injury

Identifiers

PMID34708087
PMCPMC8542768
OpenAlexW3205471435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.